inclisiran

Ukraine

Drugs containing this active substance

  • SIBRAVA

    The drug is indicated for the treatment of adults with elevated cholesterol levels (primary hypercholesterolemia or mixed dyslipidemia). It is used as an adjunct to diet if the maximum dose of statins does not allow for reaching the target cholesterol level, or if the patient cannot take statins due to contraindications or intolerance.

    Form: solution for injection

    Active substance Dosage
    inclisiran 284 mg/1.5 ml

    ATC: C10AX16

    Manufacturer: Novartis Pharmaceutical Manufacturing GmbH (manufacturing, quality control (partial), primary packaging, secondary packaging, batch release; quality control (partial))